BCG Tuberculosis Vaccine: Immunological and Clinical Efficacy in Children Born to HIV-Infected Women

BCG Tuberculosis Vaccine: Immunological and Clinical Efficacy in Children Born to HIV-Infected Women

The article analyses the efficacy of vaccination and its influence on the nature of tuberculosis process in children perinatally exposed to HIV. The study analysed hospital records, hospital discharge summaries and outpatient medical records of children under 14 with tuberculosis: there were 109...

Full description

Bibliographic Details
Main Authors:	N. I. Klevno, V. A. Aksenova
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-06-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	tuberculosis bcg vaccine vaccine efficacy and safety hiv infection hiv-exposed children mantoux test
Online Access:	https://www.biopreparations.ru/jour/article/view/138

Similar Items

Mantoux test results and BCG vaccination status in TB-exposed children
by: Fadilah Harahap, et al.
Published: (2015-03-01)

An evaluation of the results of mantoux test in children received BCG vaccine during the neonatal period
by: M.H Daei-Parizi, et al.
Published: (2001-12-01)

Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial
by: Victoria Nankabirwa, et al.
Published: (2017-03-01)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
by: Enric Vidal, et al.
Published: (2017-08-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)

Mantoux Test in Under-five Children Visiting the out~patient Child Clinic of Dr. Pirngadi Hospital, Medan
by: A. Razak Dalimunthe, et al.
Published: (2019-01-01)

Fighting Tuberculosis: In Search of a BCG Replacement
by: Nonna I. Nadolinskaia, et al.
Published: (2022-12-01)

Difference in Severity of Tuberculosis in Children with or without a BCG Scar
by: Gunadi Santosa, et al.
Published: (2019-04-01)

Frequency of absent BCG Scar in Babies Vaccinated with BCG
by: Aqeela Sami, et al.
Published: (2023-07-01)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
by: Paola Villanueva, et al.
Published: (2023-04-01)

The role of BCG in prevention of tuberculosis and the strategies to improve its immunogenicity
by: Jolanta Mazurek
Published: (2018-03-01)

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
by: Athina Kilpeläinen, et al.
Published: (2019-08-01)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
by: Hazel M. Dockrell, et al.
Published: (2017-09-01)

A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV
by: Alex J. Warr, et al.
Published: (2022-06-01)

THE INFLUENCE OF BCG VACCINATION ON THE STRUCTURE OF CLINICAL FORMS OF TUBERCULOSIS IN CHILDREN FROM THE FOCI OF INFECTION AND FROM UNSPECIFIED CONTACT FOR TUBERCULOSIS
by: U.YU. SIRODJIDINOVA, et al.
Published: (2018-08-01)

Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study
by: Birger Trollfors, MD, et al.
Published: (2021-08-01)

Tuberculin conversion rate after BCG vaccination of apparently healthy infants in a resource-poor setting
by: Eziamaka J Enemuo, et al.
Published: (2022-01-01)

A profile of cutaneous tuberculosis
by: Patra Apares, et al.
Published: (2006-01-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)

A review of the BCG vaccine and other approaches toward tuberculosis eradication
by: Thomas Cho, et al.
Published: (2021-08-01)

Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
by: Aakash Mahant, et al.
Published: (2017-08-01)

Vacina BCG: eficácia e indicações da vacinação e da revacinação BCG vaccine: efficacy and indications for vaccination and revaccination
by: Mauricio L. Barreto, et al.
Published: (2006-07-01)

Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)

Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates
by: Ruihuan Wang, et al.
Published: (2023-11-01)

Osteíte por BCG Osteitis after BCG vaccination
by: André Fukunishi Yamada, et al.
Published: (2009-03-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: Vladimir Yeremeev, et al.
Published: (2019-03-01)

Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
by: Afifah Machlaurin, et al.
Published: (2020-11-01)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01)

IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model
by: Shelby D. Bradford, et al.
Published: (2024-02-01)

Nonclinical Development of BCG Replacement Vaccine Candidates
by: Bernd Eisele, et al.
Published: (2013-04-01)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
by: Narcís Saubi, et al.
Published: (2020-11-01)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol <i>M. tuberculosis</i> Challenge in Rhesus Macaques
by: Andrew D. White, et al.
Published: (2020-04-01)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
by: Harindra D. Sathkumara, et al.
Published: (2019-03-01)

Estimativa do risco de infecção tuberculosa em populações vacinadas pelo BCG Determining the risk of tuberculosis infection in BCG-vaccinated populations
by: Gilberto Ribeiro Arantes, et al.
Published: (1992-04-01)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
by: Gil R. Diogo, et al.
Published: (2019-06-01)

Therapeutic Approach in Complications of BCG Vaccinations in Children
by: I.P. Zhurilo, et al.
Published: (2013-05-01)

The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China
by: Wei Huang, et al.
Published: (2022-09-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)